Premium
Relationship Between Serum Potassium Concentration and Risk of Recurrent Ventricular Tachycardia or Ventricular Fibrillation
Author(s) -
MICHAUD GREGORY F.,
STICHERLING CHRISTIAN,
TADA HIROSHI,
ORAL HAKAN,
PELOSI FRANK,
KNIGHT BRADLEY P.,
MORADY FRED,
STRICKBERGER S. ADAM
Publication year - 2001
Publication title -
journal of cardiovascular electrophysiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.193
H-Index - 138
eISSN - 1540-8167
pISSN - 1045-3873
DOI - 10.1046/j.1540-8167.2001.01109.x
Subject(s) - medicine , ventricular fibrillation , cardiology , ventricular tachycardia , ejection fraction , heart disease , potassium , fibrillation , atrial fibrillation , heart failure , chemistry , organic chemistry
Serum Potassium and Defibrillator Shocks.Introduction: Electrolyte abnormalities are considered a correctable cause of a life‐threatening ventricular arrhythmia according to American Heart Association/American College of Cardiology Practice Guidelines, and ventricular tachycardia or ventricular fibrillation in the setting of an electrolyte abnormality is considered a class III indication for defibrillator implantation. However, there are little data to support this recommendation. The purpose of this study was to determine the risk of a recurrent sustained ventricular arrhythmia in patients with a low serum potassium concentration at the time of an initial episode of a sustained ventricular arrhythmia. Methods and Results: One hundred sixty‐nine consecutive patients who presented with a sustained ventricular arrhythmia and a serum potassium concentration determined on the day of the arrhythmia underwent defibrillator implantation. All patients had structural heart disease and left ventricular ejection fraction of 0.32 ± 0.15. On the day of the index arrhythmia, 30% of the patients had a serum potassium concentration < 3.5 or > 5.0 mEq/L, including 7% who had a serum potassium concentration < 3.0 or > 6.0 mEq/L. For the entire cohort of patients, freedom from a recurrent sustained ventricular arrhythmia was 18% at 5 years and was not significantly different among patients with a serum potassium concentration < 3.5 mEq/L (23%), between 3.5 and 5.0 mEq/L (16%), and > 5.0 mEq/L ( 5%; P = 0.1 ). Conclusion: The results of the present study suggest that patients with structural heart disease and an abnormal serum potassium concentration at the time of an initial episode of sustained ventricular tachycardia or ventricular fibrillation are at high risk for a recurrent ventricular arrhythmia; therefore, implantable defibrillator therapy may be reasonable.